Last ¥746.00 JPY
Change Today +11.00 / 1.50%
Volume 6.2K
7703 On Other Exchanges
Symbol
Exchange
Tokyo
As of 12:49 AM 12/26/14 All times are local (Market data is delayed by at least 15 minutes).

kawasumi laboratories inc (7703) Snapshot

Open
¥741.00
Previous Close
¥735.00
Day High
¥746.00
Day Low
¥737.00
52 Week High
08/26/14 - ¥835.00
52 Week Low
05/14/14 - ¥593.00
Market Cap
17.1B
Average Volume 10 Days
22.2K
EPS TTM
¥57.79
Shares Outstanding
22.9M
EX-Date
03/27/15
P/E TM
12.9x
Dividend
¥15.00
Dividend Yield
2.01%
Current Stock Chart for KAWASUMI LABORATORIES INC (7703)

Related News

No related news articles were found.

kawasumi laboratories inc (7703) Related Businessweek News

No Related Businessweek News Found

kawasumi laboratories inc (7703) Details

Kawasumi Laboratories, Incorporated manufactures and sells medical devices and pharmaceutical products in Japan. The company’s hemodialysis products include dialyzers, blood tubing lines, A.V. fistula needles, and isotonic sodium chloride solutions; and blood collection and transfusion products, such as blood bags, platelet storage bags, and potassium adsorption filters. It also provides infusion therapy products comprising port access infusion sets and winged blood collection sets. In addition, the company offers plasmapheresis system, which is designed for the removal of pathogenic factors from patients' blood by extracorporeal circulation. Its plasmapheresis systems include plasma fractionators and plasma separators. Kawasumi Laboratories, Incorporated was founded in 1954 and is headquartered in Tokyo, Japan.

2,715 Employees
Last Reported Date: 06/19/14
Founded in 1954

kawasumi laboratories inc (7703) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

kawasumi laboratories inc (7703) Key Developments

Kawasumi Laboratories Inc. to Report Q2, 2015 Results on Nov 11, 2014

Kawasumi Laboratories Inc. announced that they will report Q2, 2015 results on Nov 11, 2014

Cerus Corporation Announces Agreement with Kawasumi Laboratories for the Development of INTERCEPT Platelets Kits in Japan

Cerus Corporation announced that it has entered into a partnership agreement with Kawasumi Laboratories to develop an INTERCEPT platelet kit designed for use in Japan.

Kawasumi Laboratories Inc. to Report Q1, 2015 Results on Aug 08, 2014

Kawasumi Laboratories Inc. announced that they will report Q1, 2015 results on Aug 08, 2014

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
7703:JP ¥746.00 JPY +11.00

7703 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Fresenius Medical Care AG & Co KGaA €61.18 EUR -0.385
View Industry Companies
 

Industry Analysis

7703

Industry Average

Valuation 7703 Industry Range
Price/Earnings 11.8x
Price/Sales 0.6x
Price/Book 0.4x
Price/Cash Flow 10.2x
TEV/Sales 0.1x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact KAWASUMI LABORATORIES INC, please visit www.kawasumi.jp. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.